Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07183267

Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving Radiotherapy

Reducing rAdiation aDverse Effects of dermatitIs and mucosAl inflammatioN Using Red Light Therapy

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
248 (estimated)
Sponsor
The Christie NHS Foundation Trust · Academic / Other
Sex
All
Age
0 Years – 16 Years
Healthy volunteers
Not accepted

Summary

The goal of this interventional study is to see if the daily use of red light therapy called photobiomodulation can help sore skin and sore mouths in children having radiotherapy. All children aged 0-16 years old who are receiving either proton or photon radiotherapy treatment, except to the brain only, will be asked if they would like to join the study. The main questions it aims to answer are: 1. Does the use of red light therapy help the skin side effects in children and young people undergoing proton or photon therapy? 2. Does the use of red light therapy help the mouth side effects in children and young people undergoing proton or photon therapy in the head and neck area? Researchers will compare the patients enrolled on to the study with a like for like historic patient to see if red light therapy improves the sore skin and sore mouths caused by proton or photon therapy. Participants will have a daily treatment with red light therapy alongside their daily proton or photon treatment fraction.

Conditions

Interventions

TypeNameDescription
DEVICEPhotobiomodulationParticipants will receive a daily treatment of photobiomodulation via a LED photobiomodulation device alongside their proton or photon treatment fraction. The photobiomodulation will be administered to the skin in the site of the patients proton or photon therapy treatment area.

Timeline

Start date
2026-06-01
Primary completion
2028-06-01
Completion
2028-10-01
First posted
2025-09-19
Last updated
2026-03-19

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07183267. Inclusion in this directory is not an endorsement.